Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3CMGM5
Thu, 27.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched   Preliminary Single Pill revenue declines by 32% to EUR 12.1 million in first half of 2023 (H1 2022: EUR 17.7 million), mainly due to delivery delays Preliminary total reve [ … ]
Technical analysis
To the publication
Thu, 27.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched   Preliminary Single Pill revenue declines by 32% to EUR 12.1 million in first half of 2023 (H1 2022: EUR 17.7 million), mainly due to delivery delays Preliminary total reve [ … ]
Technical analysis
To the publication
Thu, 27.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 Monheim am Rhein, 27 July 2023. APONTIS PHARMA AG (“APONTIS PHARMA” or “Company“, Ticker APPH / ISIN DE000A3CMGM5) has withdrawn today its forecast for fiscal year 2 [ … ]
Technical analysis
To the publication
Thu, 27.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 Monheim am Rhein, 27 July 2023. APONTIS PHARMA AG (“APONTIS PHARMA” or “Company“, Ticker APPH / ISIN DE000A3CMGM5) has withdrawn today its forecast for fiscal year 2 [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as successor Monheim, 10 July 2023. The Chief Executive Officer (CEO) of APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, Karl-Heinz Gast, has informed the Supervisor [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as successor Monheim, 10 July 2023. The Chief Executive Officer (CEO) of APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, Karl-Heinz Gast, has informed the Supervisor [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons Monheim am Rhein, 10 July 2023. The Chief Executive Officer (CEO) of APONTIS PHARMA AG (“APONTIS PHARMA” or “Company“, Ticker APPH / ISIN DE000A3CMGM5), Karlheinz Gast, has infor [ … ]
Technical analysis
To the publication
Mon, 10.07.2023       APONTIS PHARMA AG
DE000A3CMGM5

Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons Monheim am Rhein, 10 July 2023. The Chief Executive Officer (CEO) of APONTIS PHARMA AG (“APONTIS PHARMA” or “Company“, Ticker APPH / ISIN DE000A3CMGM5), Karlheinz Gast, has infor [ … ]
Technical analysis
To the publication
Thu, 29.06.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of three launches in 2023   Single Pill Finder online application shows real-time options to simplify therapy Free-of-charge physician assistance system for convenient continuation of loose combination as Single Pill New Single Pill Rosazimib on the mark [ … ]
Technical analysis
To the publication
Thu, 29.06.2023       APONTIS PHARMA AG
DE000A3CMGM5

APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of three launches in 2023   Single Pill Finder online application shows real-time options to simplify therapy Free-of-charge physician assistance system for convenient continuation of loose combination as Single Pill New Single Pill Rosazimib on the mark [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.09.2024, Calendar Week 38, 266th day of the year, 100 days remaining until EoY.